cbdMD Receives Prestigious U.S. Hemp Authority™ Certification
11 May 2021 - 12:00AM
Business Wire
cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the nation’s
leading and most highly trusted and recognized cannabidiol (CBD)
brands, announced today that it has received the prestigious U.S.
Hemp Authority™ Certification (USHA).
The certification signifies the Company's efforts to provide a
high-quality, trustworthy product and grants the right to use the
Certified Seal of the U.S. Hemp Authority on all hemp product
packaging and marketing materials. In addition to the Company’s NSF
GMP registration, the USHA Certification further validates that
cbdMD adheres to the highest standards and provides consumers with
the highest quality hemp extracted cannabinoid products.
Issued by leading food standards auditing company Food Chain ID,
the USHA Certification includes a third party audit which covers
topics such as maintaining a quality management system, meeting
applicable ISO and cGMP standards, implementing standard operating
procedures, and ensures compliance with relevant Federal
regulations.
“We know that consumers choose cbdMD because of the commitment
we make to the quality and safety of our products. As a market
leader and leading recognized consumer CBD brand, it is critical
that our consumers know that when they use a cbdMD product it is
double-tested by third-party laboratories for purity and potency
and that our manufacturing has been audited and validated to meet
GMP by NSF, and now we have added the highly coveted U.S. Hemp
Authority Certification,” said Martin Sumichrast, Chairman &
Co-CEO of cbdMD, Inc.
About cbdMD, Inc.
cbdMD, Inc. is one of the leading and most highly trusted and
most recognized cannabidiol (CBD) brands with a comprehensive line
of U.S. produced, THC-free1 CBD products. Our cbdMD brand currently
includes over 130 SKUs of high-grade, premium CBD products
including CBD tinctures, CBD gummies, CBD topicals, CBD capsules,
CBD bath bombs, CBD bath salts, CBD sleep aids and CBD drink mixes.
Our Paw CBD brand of pet products includes over 45 SKUs of
veterinarian-formulated products including tinctures, chews,
topicals products in varying strengths, and our CBD Botanicals
brand of beauty and skincare products features 15 SKUs, including
facial oil and serum, toners, moisturizers, clear skin, facial
masks, exfoliants and body care. To learn more about cbdMD and
their comprehensive line of U.S. grown, THC-free1 CBD oil products,
please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook,
or visit one of the 6,000 retail outlets that carry cbdMD
products.
1 THC-free is defined as below the level of detection using
validated scientific analytical methods.
Forward-Looking Statements
This press release contains certain forward-looking statements
that are based upon current expectations and involve certain risks
and uncertainties within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Such forward-looking statements can
be identified by the use of words such as ''should,'' ''may,''
''intends,'' ''anticipates,'' ''believes,'' ''estimates,''
''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and
''proposes.'' These forward-looking statements are not guarantees
of future performance and are subject to risks, uncertainties, and
other factors, some of which are beyond our control and difficult
to predict and could cause actual results to differ materially from
those expressed or forecasted in the forward-looking statements.
You are urged to carefully review and consider any cautionary
statements and other disclosures, including the statements made
under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on
Form 10-K for the fiscal year ended September 30, 2020 as filed
with the Securities and Exchange Commission (the "SEC") on December
22, 2020, Item 1A. Risk Factors, contained in our Quarterly Report
on Form 10-Q for the period December 31, 2020 as filed with the SEC
on February 9, 2021 and our other filings with the SEC. All
forward-looking statements involve significant risks and
uncertainties that could cause actual results to differ materially
from those in the forward-looking statements, many of which are
generally outside the control of cbdMD, Inc. and are difficult to
predict. cbdMD, Inc. does not undertake any duty to update any
forward-looking statements except as may be required by law. The
information which appears on our websites and our social media
platforms, including, but not limited to, Instagram and Facebook,
is not part of this press release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210510005191/en/
PR: 5W Public Relations cbdMD@5wpr.com (212) 999-5585
Investors: cbdMD, Inc. John Weston Director of Investor
Relations John.Weston@cbdMD.com (704) 249-9515
cbdMD (AMEX:YCBD)
Historical Stock Chart
From Apr 2024 to May 2024
cbdMD (AMEX:YCBD)
Historical Stock Chart
From May 2023 to May 2024